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Running Title: Piracetam misuse: a review of online reports 
 
Abstract 
Introduction: Performance and Image Enhancing Drugs (PIED), also known as “lifestyle drugs”, 
are increasingly sold on the Internet to enhance cognitive as well as sexual, muscular, attentive and 
other natural capacities. Our analysis focus on the misuse of the cognitive enhancer Piracetam. 
Methods: A literature review was carried out in PsychInfo and Pubmed database. Considering the 
absence of peer-reviewed data, additional sources of unstructured information from the Internet 
was carried out between February 2012 and July 2013. Additional searches were conducted using 
the Global Public Health Intelligence Network (GIPHIN), a secure Internet-based early warning 
system developed by Health Canada and the World Health Organization (WHO), which monitors 
media reports in six languages, Arabic, Chinese, English, French, Russian and Spanish. 
Results: Piracetam is sold via illicit online pharmacies with no need of prescription at low prices. 
Buyers, mainly healthy individuals, purchase the product to enhance study and work-related 
performances as well as for recreational purposes.  Its non-medical use is often associated with the 
occurrence of side effects such as hallucinations, psychomotor agitation, dysphoria, tiredness, 
dizziness, memory loss, headache and severe diarrhea; moreover, several users declared to not 
have felt any cognitive improvement nor psychedelic effects.  
Conclusions: This is a new and fast growing trend of abuse that needs to be extensively monitored 
and studied also by using near real-time and unstructured sources of information such as Internet 
news and online reports in order to acquire rapid knowledge and understanding. Products sold 
online might be counterfeits and this enhances the health risks. 
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1. INTRODUCTION 
In recent years, a rapidly spreading of substances known as ‘Performance and Image Enhancing 
Drugs’ (PIED), also known as ‘lifestyle drugs’, has been recorded (Evans-Brown, McVeigh, 
Perkins, & Bellis, 2012). PIEDs are mainly sold online, via illicit online pharmacies, as the most 
immediate way to enhance cognitive, sexual, muscular, attentive and other natural capacities, even 
if their level of safety, composition and legal status are mostly unknown (European Monitoring 
Centre for Drugs and Drug Addiction [EMCDDA], 2010; EMCDDA, 2011; Advisory Council on 
the Misuse of Drugs [ACMD], 2011; Corazza, et al., 2011; Schifano, et al., 2006; Larance, 
Degenhardt, Copeland, & Dillon, 2008). These also include pharmaceutical products, which can be 
bought without a prescription and at discounted prices, such as Pregabalin and Adderall (Orizio, et 
al., 2009; Littlejohn, Baldacchino, Schifano, & Deluca, 2005).  
In particular, this article will focus on Piracetam, a cognitive enhancer, which has been abused by 
healthy individuals to enhance their functions in study and work-related performances (Schifano, et 
al., 2003; Corazza, et al., 2013). 
Piracetam is a cyclic derivative of the neurotransmitter γ-aminobutyric acid (GABA), originally 
marketed in 1971 by UCB Pharma. It was the first ‘nootropic’ drug (Giurgea, 1972), an agent that 
acts on cognitive function without causing sedation or stimulation (Winblad, 2005). It was found 
originally to be effective as a protective agent in hypoxia-induced amnesia. 
Although piracetam is a derivative of GABA, its mechanism of action appears to be unrelated to the 
properties of this neurotransmitter. Piracetam affects a number of neuronal proteins; some evidence 
suggests that piracetam can act at the α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid 
(AMPA) receptor as an allosteric modulator binding in six different positions (Ahmed & Oswald, 
2010) and that it may have an effect on NMDA glutamate receptors (Cohen & Müller, 1993). 
However, while the exact mode of action of piracetam is a matter of debate, there is increasing 
evidence that its underlying effect is to restore cell membrane fluidity (Fassoulaki, 
Kostopanagiotou, Kaniaris, & Varonos, 1985; Peuvot, Schank, Deleers, & Brasseur, 1995). 
Restored membrane fluidity induced by Piracetam may have a number of physiological 
consequences including restored neurotransmission (Winblad, 2005), increased oxygen 
consumption in the brain (Jordaan, Oliver, Dormehl, & Hugo, 1996), enhanced neuroplasticity 
(Brandao, et al., 1996), neuroprotection (Brandao, Paula-Barbosa, & Cadete-Leite, 1995) and 
anticonvulsant action (Benesova, 1980).  
Consistent with its varied pharmacological effects, Piracetam has documented benefit in a diverse 
range of indications. The largest amount of data is about the therapeutics use of Piracetam to treat 
early Alzheimer’s disease and age-associated memory impairment (Waegemans, et al., 2002); a 
large meta-analysis of all available clinical studies provided compelling evidence for the global 
efficacy of piracetam in a diverse group of older subjects with cognitive impairment (Waegemans, 
et al., 2002). This proposal was later supported by observations that piracetam specifically enhances 
membrane fluidity in aged brain material, showing no effect in membranes from young brains 
(Müller, et al., 1997).  
In addition to Alzheimer’s disease and age-associated memory impairment, Piracetam showed good 
clinical outcomes in the treatment of a range of neuropsychiatric disorders including vertigo, 
cortical myoclonus, dyslexia, neuropathic pain and tardive dyskinesia (Winblad, 2005; Danilova 
Grafova, & Reshetniak, 1996; Libov, et al., 2007).  
Piracetam doses usually range between 2.4 g/die and 8 g/die, even if in the treatment of cortical 
myoclonus it can be administered at higher dosages (up to 24 g/die) (Winblad, 2005). 
In this context, the present study aims to identify and investigate the non-medical use of Piracetam, 
while collecting unprecedented information on its psychoactive effects. 
 
2. MATERIALS AND METHODS 
The literature on Piracetam misuse was searched in PsychInfo and Pubmed databases. Considering 
the absence of peer-reviewed data on its misuse, results were integrated with a multilingual 
qualitative assessment of a range of websites, drug fora and other online resources (i.e.: 
newsgroups, chatrooms, mailing lists, e-newsletters, bulletin boards and videos). Between February 
2012 and July 2013, exploratory qualitative searches of 227 websites have been carried out in 
English using generic and specific keywords, such as “legal highs”, “research chemicals”, “online 
pharmacy”, “piracetam”, and “nootropil” in the Google search engine. These websites were 
monitored on a regular basis, daily (n=32), weekly (n=168) or monthly (n=27) depending on 
relevance. Links from forums, websites and other related material, including newspapers and 
magazines, were followed as well. Additional searches were carried out in the database provided by 
the Global Public Health Intelligence Network (GPHIN). This is a secure Internet-based early 
warning system that gathers preliminary reports of public health significance by monitoring global 
media sources in near 'real-time', 24  hours a day, 7 days a week basis. GPHIN is operated by the 
Public Health Agency of Canada, and monitors news sources and websites across the globe in 9 
languages (e.g. English, French, Farsi, Portuguese, Arabic, Russian, Spanish, and Chinese 
simplified/traditional) (Keller, et al., 2009). While a series of algorithms are used and adjusted to 
capture relevant information, analysis of relevant data since 2003 was also carried out manually by 
a multidisciplinary and multilingual team of analysts. Permission for the study was granted by the 
School of Pharmacy Ethics Committee, Hatfield, UK (15 December, 2010; PHAEC/10-42). 
 
3. RESULTS 
Piracetam is sold online via illicit websites with no need for prescription (see Table 1). Some 
retailers require an initial ‘online consultation’ with an unknown ‘cyber-doctor’ before shipping 
their products in return for online credit-card payment. Products are then sent directly to the buyers, 
but these are often counterfeits as recently alerted by the US Food and Drug Administration (FDA) 
(2010). 
Prices of piracetam vary according to the retailers from about 0.70 to 1.10 € for 1 gram; it is mainly 
sold in form of tablets and bulk powder (Nootropic reviews, 2013; Nootrabiolabs, 2013) (Table 1). 
Videos on the YouTube featuring how to use piracetam, where to get it, its effects and its dosages 
also emerged from our searches (Piracetam Smart Drug Secret, 2010; Smart drugs make learning 
easier, 2010; Piracetam Review, 2011). 
A summary of the characteristics of the non-medical use of piracetam is showed in Table 2. 
 
3.1 Piracetam as a cognitive enhancer for non-medical purposes 
Piracetam appears to be widely used by healthy individuals to enhance cognitive functions in study 
and work-related performances. The majority of the users report satisfactory improvements in 
different cognitive functions including learning, memory, concentration and ‘verbal intelligence’. It 
is taken orally with dosages up to 9.6 g/die. It is often assumed in concomitance with other 
psychoactive supplements including choline, caffeine, adderall and acetylcarnitine (Drugs-forum, 
2006a; Longecity, 2007; Brainmeta, 2011). A selected number of personal accounts has been 
reported in Table 3. 
 
3.2 Piracetam as a recreational drug 
In addition to its cognitive enhancing features, piracetam is widely used from polydrug abusers for 
its psychedelic effects. It appears to have hallucinogenic and mood improving effects and appears to 
enhance dream experiences. It is taken orally at dosages up to 80 g/die or through nasal 
insufflations at dosages up to 7 g/die. Piracetam is often ingested in combination with other 
recreational drugs to enhance the power of their positive effects, to reduce their unwanted negative 
effects and to improve sensory feelings. In particular, there are several reports about its concomitant 
use with ketamine, methamphetamine, LSD, cocaine, alcohol, and kratom (Drugs-forum, 2005; 
Drugs-forum, 2006b; Drugs-forum, 2009a; Drugs-forum, 2009b; Drugs-forum, 2011; Erowid 
Experience Vault, 2007; Erowid Experience Vault, 2008). Some relevant users’ experiences are 
reported in Table 3. 
 
3.3 Unwanted effects 
Several misusers reported unwanted side effects related to Piracetam. The severity of the effects 
seems to be dose-dependent; however, as the online sources are largely imprecise, it is not possible 
to postulate a clear relation between dosages and effects. The unwanted side effects reported from 
Piracetam misusers include psychomotor agitation, dysphoria, ‘feeling weird’, tiredness, dizziness, 
memory loss, headache and severe diarrhoea; moreover, several users declared to not have felt any 
cognitive improvement nor psychedelic effects (Drugs-forum, 2005; Drugs-forum, 2006b; Drugs-
forum, 2011). 
 
4. DISCUSSION 
To the best of our knowledge, this is the fist study on the non-medical use of piracetam, which 
uncovers previously unknown psychoactive effects. 
Prescription drugs such as piracetam are nowadays widely accessible on the web through online 
pharmacies (Schifano, et al., 2006). These are often illicit; they do not guarantee drugs’ quality and, 
in 81.4% of cases, they sale medications without any medical prescription (Orizio, et al., 2009; 
Littlejohn, Baldacchino, Schifano, & Deluca, 2005). Marketing strategies are used to appear 
professional and trustable health websites, while showing pictures of doctors or licensed 
pharmaceutical products. In this context, it appears clear why the issue of the misuse of prescription 
drugs is continuously becoming more relevant (Bersani, et al., 2013; Schifano, et al., 2011; 
Schifano, et al., 2013). 
In terms of misuse characteristics, piracetam can be considered both a ‘common’ recreational and a 
performance enhancing drug (Graham, et al., 2009) taken by individuals who aim to enhance their 
personal and professional performances. At the same time, as it emerged from online anecdotal 
reports examined in this study, they are usually aware that they do something unhealthy; for this 
reason, they are alerted about possible adverse effects that these products might induce and they are 
usually prepared to ask medical assistance, when necessary. On the other hand, they do not consider 
themselves drug addicts. This can lead to various health risks, including the consumption of 
pharmaceutical product without any medical supervision, or a counterfeit medicine with unknown 
containing possibly toxic contaminants. 
The misuse of piracetam to achieve enhanced professional results was found to be very popular; 
indeed, several reports were written in Italian (TGMOnline, 2008; Myhelpforum, 2012), and a 
range of related YouTube videos were here identified (Piracetam Smart Drug Secret, 2010; Smart 
drugs make learning easier, 2010; Piracetam Review, 2011). Most of the users feel safe with 
piracetam and it seems that the general belief is that piracetam can be taken at any dosage without 
any risk; this attitude probably stems from the high dosages of Piracetam usually prescribed by 
physicians (expressed in grams and not in milligrams) and from the general idea that something that 
is legal must necessary be safe (Corazza, et al., 2013). Conversely, the misuse of piracetam as a 
recreational drug seems to be limited to individuals, often marginalized, with a history of 
recreational polydrug misuse. 
From a clinical point of view, although cases of piracetam dependence have not been described, 
physicians should be aware of Piracetam misuse issues, so that signs and symptoms of possible 
piracetam side effects may be recognized. Moreover, as Piracetam is often sold through unreliable 
online sources, misusers may present with an increased risk of ingesting a range of adulterated 
products with potential toxic effects (Evans-Brown, McVeigh, Perkins, & Bellis, 2012). 
When considering the question of who might use online pharmacies to buy Piracetam or other 
drugs, it is possible to identify at least three prerequisites. These are (1) literacy: using the Internet 
to order drugs requires basic literacy and numeracy skills; (2) Internet access: the largest increase in 
Internet access has been seen in those with the highest incomes; and (3) credit-card ownership. In 
summary, these misusers are most likely to come from the socioeconomically privileged sections of 
society, where high levels of education and employment are likely to be the rule rather than the 
exception. For these reasons, the stereotypical image of the ‘drug abusing patient’ may need to 
change, in favour of a new class of ‘expert’ patients who use a website to obtain a self diagnosis and 
a treatment. 
One could wonder about the limitations of carrying out a risk of misuse assessment of a drug whilst 
taking into account the online comments only; in fact, it may be inappropriate to trust information 
obtained from the Internet without independent verification. However, in absence of relevant peer-
reviewed data, this seems to be the only method to obtain preliminary information about new and 
emerging phenomena (Schifano, et al., 2003; Schifano, et al., 2010); moreover, the web monitoring 
has proved that Internet is an important source of information for understanding users’ point of 
view about the effects of drugs: writing in a web forum allows the user to hide his/her personal 
information and to write without any hesitation. 
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Nootropil 1200mg 180 pills $99.00  
Nootropil 1200mg 240 pills $125.00 
Generic Piracetam 400mg 100 pills $20.00 
Generic Piracetam 400mg 200 pills  $35.00 
Generic Piracetam 400mg 300 pills $49.00 
Generic Piracetam 400mg 400 pills $65.00 
http://www.nootra
biolabs.com/index.
php?route=product
/search&filter_nam
e=piracetam 
Piracetam 100g bulk powder $ 9.99 
Piracetam 200g bulk powder $ 19.99 
Piracetam 500g bulk powder $ 47.99 
 
Table 1. Examples of Piracetam prices reported in pharmacies on line 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reasons Descriptions 
 
Online availability Piracetam is easy to purchase over the Internet, 
where it is sold at a discounted rate and may be 
adulterated 
Price Prices of Piracetam sold online vary from about 
0.70 to 1.10 € for 1 gram; 
Effects Improvement in learning, memory, 
concentration and “verbal intelligence”; 
hallucinations; mood improvement; 
enhancement of dream experiences 
Dosages and way of assumption As a cognitive enhancer it is taken orally with 
dosages up to 9.6 g/die. As a psychedelic drug it 
is taken orally at dosages up to 80 g/die or 
through nasal insufflations at dosages up to 7 
g/die 
Use in combination with 
other substances 
It is often assumed in concomitance with other 
cognitive enhancers such as choline, caffeine, 
adderall and acetylcarnitine or other 
psychoactive drugs such as ketamine, 
methamphetamine, LSD, cocaine, alcohol, and 
‘kratom’/Mytragina speciosa 
Side effects Psychomotor agitation, dysphoria, “feeling 
weird”, tiredness, dizziness, memory loss, 
headache and severe diarrhea 
Misusers Misusers are generally students who use 
piracetam to improve their cognitive 
performances and/or polydrug abusers who use 
it to experience a range of psychedelic states 
 
Table 2: Summary of the characteristics of the non-medical use of Piracetam 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Piracetam as a cognitive enhancer for non-medical purposes 
 
I am studying spanish right now pretty intensely, and piracetam is one of many among my supplement 
arsenal.  I can tell you that it is much easier for me to memorize vocab and verbs.  Also, I am becoming 
more and more fluent by the day.  I believe that piracetam is enabling me comprehend and conversate in 
spanish very well.  Granted, I took 3 years in high school and 3 quarters in college, but now that I am self-
learning "the rest", it is all coming together quite nicely. Piracetam provides me with extreme focus and an 
unreal ability to memorize though (Longecity, 2007). 
I take 1.2-1.6 g of piracetam 3 times a day 4-5 hours spaced out between dosages. I take around 1.5-2.1g of 
choline bitartrate with my breakfast. I would also add some acetyl-l-carnitine to the mix, around 1-3 g a 
day.  The dosage, I believe, have a whole lot to do with the end-product you will experience. Superhuman 
memory?  Well, just as a little marker of results, I've been periodically tested my digit span on the braingle 
site. I'm up to 14 now (Treato, 2013). 
I've used 1000mg of piracetam with 500mg choline source. It works, whatever that means. You feel more 
articulate and you can literally feel your head throb. I found improved verbal intelligence more than 
anything. Everything seemed to require less effort, there were less mental blocks etc. I noticed my typing 
speed improved, although I made more spelling errors (Brainmeta, 2011). 
SWIM often used caffeine (500-600mg) with an attack dose of piracetam (8000mg) for staying awake at 
night for learning. The combo works well, it really helps SWIM focus (Drugs-forum, 2006b). 
 
Effects of Piracetam as an hallucinogenic/recreational drug 
 
Back in the store, the colors and the entire scene stood out to me. In particular, I had a slightly empathic 
experience where I felt the negative/fear/frustration energies of all the people in the room (Erowid 
Experience Vault, 2007). 
I noticed that the right side of my body is more closed up than the left side and it seemed that I was able to 
direct an inner energy-flow so that the right side could open up and I became more balanced (Erowid 
Experience Vault, 2008). 
YES YES YES! It has been so relaxing! The music sounded more clear and detailed than usual and my 
attention was completely in it. I feel unusually fresh and fit, no more tiredness! Suddenly I started to dance 
spontaneously in my room (on music), just because it felt good, very satisfying! I was much more aware of 
/incontact-with my body (Erowid Experience Vault, 2008). 
The most worthwile use SWIM has found for this substance was for enhancing dreams. 1-2g taken before 
going to bed was found to enhance dream recall and vividness, helping SWIM wake more often with the 
feeling that the night had been at least as long and eventful than the day before in waking reality (Drugs-
forum, 2008). 
 
Effects of Piracetam in combination with other recreational drugs 
 
Yet all of Piracetam + LSD trips had one thing in common - they were profoundly powerful, although LSD 
dosage was 1/4 to 1/2 of what I usually take without Piracetam (Erowid Experience Vault, 2001). 
It increases many folds effects of stimulants and hallucinogens, while decreases or eliminates negative 
symptoms (Erowid Experience Vault, 2001). 
SWIM has found it to inhibit the action of Ketamine, though SWIM wished it had done so more the last time 
he sat on the edge of a bed trying to persuade his hands to cram Piracetam pills in his mouth after a 250mg 
K nightmare. SWIM has really tried to like that substance but it seems like K and SWIM just aren't meant 
for each other (Drugs-forum, 2006b). 
Meth is more intense, more happy, I need a lot less of meth, if combining it with 2400 mg of Piracetam. The 
most important part however is that even though I usually have a very hard crash from meth, accompanied 
by painful cravings, Piracetam seem to eliminate it totally. I just gradually come down and go to sleep 
(Erowid Experience Vault, 2001). 
 
Table 3. Relevant users’ experiences in relation to Piracetam misuse. SWIM: Someone Who Is Not 
Me; Met: Methamphetamine; K: Ketamine 
